GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 320 filers reported holding GW PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $212,128 | +73.6% | 978 | -7.6% | 0.01% | +50.0% |
| Q4 2020 | $122,219 | -67.4% | 1,059 | -72.5% | 0.01% | -72.7% |
| Q3 2020 | $375,187 | -22.3% | 3,854 | -2.0% | 0.02% | -29.0% |
| Q2 2020 | $482,780 | +31.6% | 3,934 | -6.1% | 0.03% | +3.3% |
| Q1 2020 | $366,743 | -19.6% | 4,188 | -4.0% | 0.03% | -6.2% |
| Q4 2019 | $456,091 | +181.8% | 4,362 | +210.0% | 0.03% | +146.2% |
| Q3 2019 | $161,847 | -28.9% | 1,407 | +6.5% | 0.01% | -31.6% |
| Q2 2019 | $227,727 | +139.5% | 1,321 | +134.2% | 0.02% | +111.1% |
| Q1 2019 | $95,073 | +110.4% | 564 | +21.6% | 0.01% | +50.0% |
| Q4 2018 | $45,189 | +25.8% | 464 | +123.1% | 0.01% | +50.0% |
| Q3 2018 | $35,930 | -57.8% | 208 | -65.9% | 0.00% | -66.7% |
| Q2 2018 | $85,119 | +0.1% | 610 | -19.2% | 0.01% | -7.7% |
| Q1 2018 | $85,066 | -51.4% | 755 | -43.1% | 0.01% | -53.6% |
| Q4 2017 | $175,177 | – | 1,327 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|